Plus Therapeutics
PSTV • NASDAQ
Plus Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marc H. Hedrick, with a market cap of $39.5M.
CEOMarc H. Hedrick
Next Earnings
Upcoming earnings announcement for Plus Therapeutics
Date
Friday, May 29, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.04
Revenue Estimate
$964.4K
Earnings History
Past 12 earnings reports for Plus Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | $0.00Est: -$0.03 | +100.0% | $1.4MEst: $1.8M | -25.7% |  10-K |
| Oct 30, 2025 | Q3 2025 | -$0.04Est: -$0.03 | -33.3% | $1.4MEst: $1.8M | -21.7% | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.01Est: -$0.11 | +90.9% | $1.4MEst: $1.6M | -11.6% | 10-Q |
| May 30, 2025 | Q1 2025 | -$1.19Est: -$0.34 | -250.0% | $1.1MEst: $1.1M | -4.6% | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.67Est: -$0.50 | -34.0% | $1.4MEst: $1.0M | +39.8% | 10-K/A |
| Nov 14, 2024 | Q3 2024 | -$0.37Est: -$0.56 | +33.9% | $1.5MEst: $1.1M | +27.7% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.71Est: -$0.53 | -34.0% | $1.3MEst: $1.7M | -23.4% | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.75Est: -$1.09 | +31.2% | $1.7MEst: $1.7M | -0.8% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$0.70Est: -$1.07 | +34.6% | $1.3MEst: $1.1M | +23.9% | 10-K |
| Oct 31, 2023 | Q3 2023 | -$1.00Est: -$1.12 | +10.7% | $1.2MEst: $1.3M | -3.9% | — |
| Aug 14, 2023 | Q2 2023 | -$0.59Est: -$1.91 | +69.1% | $1.9MEst: $790.0K | +134.7% | — |
| Apr 20, 2023 | Q1 2023 | -$2.10Est: -$1.95 | -7.7% | $506.0KEst: $740.0K | -31.6% | — |